Page - (000329) - in Biomedical Chemistry: Current Trends and Developments

Sakurada, C., Watanabe, C., & Sakurada, T. (2004). Occurrence of substance P(1-7) in the metabolism of substance P and its antinociceptive activity at the mouse spinal cord level. Methods and Findings in Experimental and Clinical Pharmacology, 26(3), 171-176. Schmidt, B., & Kuhn, C. (1998). Racemic, yet diastereomerically pure azido acids as both gamma-turn and inverse gamma-turn mimetics for solid-phase peptide synthesis. Synlett, (11), 1240-1242. Sewald, N., & Jakubke. H.-D. (2002). Peptides: Chemistry and Biology: Wiley-VCH Verlag GmbH: Weinheim. Skilling, S. R., Smullin, D. H., & Larson, A. A. (1990). Differential-Effects of C-Terminal and N- Terminal Substance-P Metabolites on the Release of Amino-Acid Neurotransmitters from the Spinal-Cord - Potential Role in Nociception. Journal of Neuroscience, 10(4), 1309-1318. Stewart, B. H., Chan, O. H., Lu, R. H., et al. (1995). Comparison of Intestinal Permeabilities Determined in Multiple in-Vitro and in-Situ Models - Relationship to Absorption in Humans. Pharmaceutical Research, 12(5), 693-699. Wacher, V. J., Silverman, J. A., Zhang, Y. C., et al. (1998). Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. Journal of Pharmaceutical Sciences, 87(11), 1322-1330. Vagner, J., Qu, H. C., & Hruby, V. J. (2008). Peptidomimetics, a synthetic tool of drug discovery. Current Opinion in Chemical Biology, 12(3), 292-296. Van de Waterbeemd, H., Camenisch, G., Folkers, G., et al. (1998). Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. Journal of Drug Targeting, 6(2), 151- 165. van de Waterbeemd, H., Smith, D. A., Beaumont, K., et al. (2001). Property-based design: optimization of drug absorption and pharmacokinetics. Journal of Medicinal Chemistry, 44(9), 1313-1333. Wang, B., Nimkar, K., Wang, W., et al. (1999). Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using coumarinic acid and phenylpropionic acid linkers. Journal of Peptide Research, 53(4), 370-382. Veber, D. F., & Freidinger, R. M. (1985). The Design of Metabolically-Stable Peptide Analogs. Trends in Neurosciences, 8(9), 392-396. Venkatachalam, C. M. (1968). Stereochemical Criteria for Polypeptides and Proteins. V. Conformation of a System of 3 Linked Peptide Units. Biopolymers, 6(10), 1425-1436. Whitby, L. R., Ando, Y., Setola, V., et al. (2011). Design, Synthesis, and Validation of a beta-Turn Mimetic Library Targeting Protein-Protein and Peptide-Receptor Interactions. Journal of the American Chemical Society, 133(26), 10184-10194. Wiktelius, D., Khalil, Z., & Nyberg, F. (2006). Modulation of peripheral inflammation by the substance P N-terminal metabolite substance P1-7. Peptides, 27(6), 1490-1497. Wiley, R. A., & Rich, D. H. (1993). Peptidomimetics Derived from Natural-Products. Medicinal Research Reviews, 13(3), 327-384. Wilmot, C. M., & Thornton, J. M. (1988). Analysis and Prediction of the Different Types of Beta- Turn in Proteins. Journal of Molecular Biology, 203(1), 221-232. Witt, K. A., Gillespie, T. J., Huber, J. D., et al. (2001). Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. Peptides, 22(12), 2329-2343. Vlieghe, P., Lisowski, V., Martinez, J., et al. (2010). Synthetic therapeutic peptides: science and